Now showing items 1-20 of 68

    • Adherence to National Guidelines for Drug Treatment of Suspected Acute Myocardial Infarction 

      McLaughlin, Thomas J.; Soumerai, Stephen Bertram; Willison, Donald J.; Gurwitz, Jerry H.; Borbas, Catherine; Guadagnoli, Edward; McLaughlin, Barbara; Morris, Nora; Cheng, Su-Chun; Hauptman, Paul J.; Antman, Elliott Marshall; Casey, Linda; Asinger, Richard; Gobel, Fredarick (American Medical Association (AMA), 1996)
      Background: Evidence-based guidelines for the treatment of patients with acute myocardial infarction (AMI) have been published and disseminated by the American College of Cardiology and the American Heart Association. Few ...
    • Adverse Outcomes of Underuse of β-Blockers in Elderly Survivors of Acute Myocardial Infarction 

      Soumerai, Stephen Bertram; McLaughlin, Thomas J.; Spiegelman, Donna Lynn; Hertzmark, Ellen; Thibault, George Edwin; Goldman, Lee (American Medical Association (AMA), 1997)
      Objectives. —To study determinants and adverse outcomes (mortality and rehospitalization) of β-blocker underuse in elderly patients with myocardial infarction; and whether the relative risks (RRs) of survival associated ...
    • Asthma Treatments and Mental Health Visits After a Food and Drug Administration Label Change for Leukotriene Inhibitors 

      Lu, Christine; Zhang, Fang; Lakoma, Matthew D.; Butler, Melissa G.; Fung, Vicki; Larkin, Emma K.; Kharbanda, Elyse O.; Vollmer, William M.; Lieu, Tracy; Soumerai, Stephen Bertram; Chen Wu, Ann (Elsevier BV, 2015)
      Purpose In 2009, the US Food and Drug Administration (FDA) mandated a label change for leukotriene inhibitors (LTIs) to include neuropsychiatric adverse events (eg, depression and suicidality) as a precaution. This study ...
    • Authors' reply to Mosholder and colleagues 

      Lu, Christine; Simon, G.; Soumerai, Stephen Bertram (BMJ, 2014)
    • Barriers to Self-monitoring of Blood Glucose Among Adults with Diabetes in an HMO: A Cross Sectional Study 

      Adams, Alyce S; Mah, Connie; Soumerai, Stephen Bertram; Zhang, Fang; Barton, Mary B; Ross-Degnan, Dennis (BioMed Central, 2003)
      Background: Recent studies suggest that patients at greatest risk for diabetes complications are least likely to self-monitor blood glucose. However, these studies rely on self-reports of monitoring, an unreliable measure ...
    • Benefits and Consequences for the Poor and the Disabled 

      Elliott, Rachel A.; Majumdar, Sumit R.; Gillick, Muriel Ruth; Soumerai, Stephen Bertram (New England Journal of Medicine (NEJM/MMS), 2005)
      The new Medicare Part D will improve access to medications for millions of Americans. One subgroup of beneficiaries, however, may inadvertently be made worse off: the 7.2 million people enrolled in both Medicaid (because ...
    • Benzodiazepine Use and Hip Fractures in the Elderly 

      Wagner, Anita Katharina; Zhang, Fang; Soumerai, Stephen Bertram; Walker, Alexander M.; Gurwitz, Jerry H.; Glynn, Robert James; Ross-Degnan, Dennis (American Medical Association (AMA), 2004)
    • Building and Evaluating a Surveillance System for Bicycle Crashes and Injuries 

      Lopez, Dahianna (2016-05-19)
      For cities aiming to create a useful surveillance system for bicycle injuries, a common challenge is that city crash reporting is scattered, faulty, or non-existent. In chapter 1, I document some of the lessons learned in ...
    • Changes in antidepressant use by young people and suicidal behavior after FDA warnings and media coverage: quasi-experimental study 

      Lu, Christine Y; Zhang, Fang; Lakoma, Matthew D; Madden, Jeanne M; Rusinak, Donna; Penfold, Robert B; Simon, Gregory; Ahmedani, Brian K; Clarke, Gregory; Hunkeler, Enid M; Waitzfelder, Beth; Owen-Smith, Ashli; Raebel, Marsha A; Rossom, Rebecca; Coleman, Karen J; Copeland, Laurel A; Soumerai, Stephen B (BMJ Publishing Group Ltd., 2014)
      Objective: To investigate if the widely publicized warnings in 2003 from the US Food and Drug Administration about a possible increased risk of suicidality with antidepressant use in young people were associated with changes ...
    • Changes in Drug Coverage Generosity and Untreated Serious Mental Illness 

      Madden, Jeanne Marie; Adams, Alyce S.; LeCates, Robert F.; Ross-Degnan, Dennis; Zhang, Fang; Huskamp, Haiden Ashby; Gilden, Daniel M.; Soumerai, Stephen Bertram (American Medical Association (AMA), 2015)
      Importance More than 1 in 5 disabled people with dual Medicare-Medicaid enrollment have schizophrenia or a bipolar disorder (ie, a serious mental illness). The effect of their transition from Medicaid drug coverage, which ...
    • Changing Surgical Antimicrobial Prophylaxis Practices through Education Targeted at Senior Department Leaders 

      Everitt, Daniel E.; Soumerai, Stephen Bertram; Avorn, Jerry Lewis; Klapholz, Henry; Wessels, Michael Robert (Cambridge University Press (CUP), 1990)
      Prescribing antibiotics for perioperative prophylaxis in common surgical procedures presents an ideal target for educational intervention. In this situation, antibiotics are often used inappropriately, with consequent ...
    • Computer-Based Drug-Utilization Review — Risk, Benefit, or Boondoggle? 

      Soumerai, Stephen Bertram; Lipton, Helene L. (New England Journal of Medicine (NEJM/MMS), 1995)
      On October 28, 1990, with little debate, Congress passed the Omnibus Budget Reconciliation Act, requiring the states to provide claims-based drug-utilization review to approximately 34 million Medicaid enrollees. The ...
    • Consultation Between Cardiologists and Generalists in the Management of Acute Myocardial Infarction 

      Willison, Donald J.; Soumerai, Stephen Bertram; McLaughlin, Thomas J.; Gurwitz, Jerry H.; Gao, Xiaoming; Guadagnoli, Edward; Pearson, Steven Donnell; Hauptman, Paul; McLaughlin, Barbara (American Medical Association (AMA), 1998)
      Background The rapid expansion of managed care in the United States has increased debate regarding the appropriate mix of generalist and specialist involvement in medical care. Objective To compare the quality of ...
    • A Controlled Trial of Educational Outreach to Improve Blood Transfusion Practice 

      Soumerai, Stephen Bertram; Salem-Schatz, Susanne; Avorn, Jerry Lewis (American Medical Association (AMA), 1993)
      Objective. —To determine whether brief, face-to-face educational outreach visits can improve the appropriateness of blood product utilization. Design. —Randomized, controlled multicenter trial with 6-month ...
    • Cost-Related Medication Nonadherence After Implementation of Medicare Part D, 2006-2007 

      Madden, Jeanne Marie; Graves, Amy; Ross-Degnan, Dennis; Briesacher, Becky A.; Soumerai, Stephen Bertram (American Medical Association, 2009)
      To the Editor: High drug costs cause some elderly or disabled patients to take less medication than prescribed or forgo basic needs to pay for medicines. The 2006 Medicare Part D drug benefit was intended to increase ...
    • Cost-Related Medication Nonadherence Among Elderly and Disabled Medicare Beneficiaries 

      Soumerai, Stephen Bertram; Pierre-Jacques, Marsha; Zhang, Fang; Ross-Degnan, Dennis; Adams, Alyce S.; Gurwitz, Jerry; Adler, Gerald; Safran, Dana Gelb (American Medical Association (AMA), 2006)
      Background Prior to implementation of the Medicare drug benefit, we estimated the prevalence of cost-related medication nonadherence (CRN) among Medicare enrollees, including elderly and nonelderly disabled beneficiarie ...
    • Cost-Related Medication Nonadherence and Spending on Basic Needs Following Implementation of Medicare Part D 

      Madden, Jeanne Marie; Graves, Amy; Zhang, Fang; Adams, Alyce S.; Briesacher, Becky A.; Ross-Degnan, Dennis; Gurwitz, Jerry H.; Pierre-Jacques, Marsha; Safran, Dana Gelb; Adler, Gerald; Soumerai, Stephen Bertram (American Medical Association (AMA), 2008)
      Context Cost-related medication nonadherence (CRN) has been a persistent problem for individuals who are elderly and disabled in the United States. The impact of Medicare prescription drug coverage (Part D) on CRN is ...
    • Costs and Consequences of Direct-to-Consumer Advertising for Clopidogrel in Medicaid 

      Law, Michael Robert; Soumerai, Stephen Bertram; Adams, Alyce S.; Majumdar, Sumit R. (American Medical Association (AMA), 2009)
      Background Direct-to-consumer advertising (DTCA) is assumed to be a major driver of rising pharmaceutical costs. Yet, research on how it affects costs is limited. Therefore, we studied clopidogrel, a commonly used and ...
    • Coverage by the News Media of the Benefits and Risks of Medications 

      Moynihan, Ray; Bero, Lisa; Ross-Degnan, Dennis; Henry, David; Lee, Kirby; Watkins, Judy; Mah, Connie; Soumerai, Stephen Bertram (New England Journal of Medicine (NEJM/MMS), 2000)
      Background The news media are an important source of information about new medical treatments, but there is concern that some coverage may be in- accurate and overly enthusiastic. Methods We studied coverage by U.S. news ...